AzTrials
AzTrials

Functional Abdominal Pain SyndromeNCT05945251

ICBT for Children With FAPDs - the Child's Pain Regulation

An observational study of Functional Abdominal Pain Syndrome, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Functional abdominal pain disorders (FAPDs) in children are common (14%) and abdominal pain has increased rapidly in children during the last ten years in Sweden. Many children with FAPDs have low quality of life, missed school days, and about 30-40% suffer from psychiatric comorbidity. Read more about this study

Who is it for?
Ages 8 to 17 yearsHealthy volunteers can take part
Conditions the study is for
Functional Abdominal Pain Syndrome
What is being tested?
Internet-delivered cognitive behavioral therapy
How many people
84 participants
Where
1 siteSweden
Study dates
1 Nov 2023to 1 Sep 2026
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Children (n=40) aged 8-17 with FAPDs who are patients at BUP Internetbehandling within the Child and Adolescent Psychiatry in Stockholm will be included in the study. Their behavioral and neural pain mechanisms will be assessed before and after Internet-CBT. We will also recruit healthy control children (n=40) aged 8-17 to compare the pain regulation between the groups. First, we will ask whether there are healthy siblings to the participating children with FAPDs that are willing to participate. If we don't get enough children by asking siblings, social media will be used in the recruitment.

Who may be able to join

  • Children 8-17 years with FAPDs: Have been offered treatment at BUP Internetbehandling for FAPDs.
  • Children 8-17 years without FAPDs: Not affected by recurrent (every week) or persistant pain during the last year.

Who cannot join

  • Contraindication for MR (metal implant or metal object in body, claustrophobia, pregnancy)

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska Institutet

    Stockholm, Karolinska Institutet, 17177

Other trials in Sweden

About this study

Official title: Individualized Online Cognitive Behavioral Therapy for Children With Functional Abdominal Pain Disorders - the Child's Pain Regulation

Functional abdominal pain disorders (FAPDs) in children are common (14%) and abdominal pain has increased rapidly in children during the last ten years in Sweden. Many children with FAPDs have low quality of life, missed school days, and about 30-40% suffer from psychiatric comorbidity. FAPDs are often sustained into adulthood and a large Swedish cohort study showed that abdominal pain during childhood is an independent strong predictor anxiety and depression later in life. Internet-cognitive behavioral therapy (Internet-CBT) can improve FAPD symptoms, but a significant number of children does not respond to the treatment.

We will here determine the pain regulation in children with FAPDs, compared with healthy controls, and assess:

Read more

What aspects of the child's pain regulation is related to improvement for children with FAPDs engaging in Internet-CBT?

Does some aspects of the child's pain regulation change during treatment?

Being tested
Internet-delivered cognitive behavioral therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet-delivered cognitive behavioral therapyOther

    Ten weekly modules for children and ten weekly modules for parents. Exposure-based cognitive behavioral therapy delivered online with asynchronous support via text messages from psychologists.

Study groups in NCT05945251
Study groupRoleWhat they receive
FAPDsChildren 8-17 years with FAPDs
Receives: Other: Internet-delivered cognitive behavioral therapy
ControlsChildren 8-17 years without FAPDs

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure pain threshold on navel

    Algometer pressure (in kPa) for the pain threshold

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  2. Unpleasantness of pressure pain threshold on navel

    Children rate their unpleasantness on a scale 0-10

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

Secondary outcomes (11)
  1. Pressure pain threshold on thigh

    Algometer pressure (in kPa) for the pain threshold

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  2. Unpleasantness of pressure pain threshold on thigh

    Children rate their unpleasantness on a scale 0-10

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  3. Conditioned pain modulation

    Conditioned pain: hand in 10°C cold water, test pain: presseure pain thresholds by algometer on the participant's thigh. Difference in pressure pain thresholds with and without the simultaneous conditioned stimuli

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  4. Temporal summation

    Pinprick stimuli of low pain, one time, then repeated 10 times. Pain after repeated stimulus minus pain for the single stimulus.

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  5. Sensory attenuation of pain

    Pressure pain thresholds (kPa) applied by the child or the experimenter. Sensory attenuation = difference in pain threshold between self-induced and experimenter induced

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  6. Resting state fMRI

    Differences in network connectivity (Yeo networks + subcortical areas) and between seed (trunk in the somatosensory cortex) to Yeo brain networks + subcortical areas).

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  7. fMRI during low pain compared with non-painful tactile stimulus

    Differences in network connectivity (Yeo networks + subcortical areas) and between seed (trunk in the somatosensory cortex) to Yeo brain networks + subcortical areas).

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  8. Pediatric Quality of Life Inventory Gastrointestinal Symptom Scale (PedsQL Gastro)

    Self-assessed questionnaire of abdominal symptoms

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  9. Faces Pain Rating Scale (FACES)

    Self-assessed questionnaire of pain intensity

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  10. Visceral sensitivity Index, child-adapted short version (VSI-C)

    Self-assessed questionnaire of gastrointestinal-specific anxiety

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

  11. Irritable bowel syndrome-behavioral responses questionnaire, child-adapted short version (BRQ-C)

    Self-assessed questionnaire of gastrointestinal-specific avoidance and controlling behaviors

    Measured: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2023
  2. Study start1 Nov 2023
  3. Primary completion1 Sep 2026
  4. Study completion1 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05945251
Sponsor's protocol ID
20223238
Status last verified
Oct 2026
First submitted
6 Jul 2023
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in